Compare TLPH & MBBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TLPH | MBBC |
|---|---|---|
| Founded | 2005 | 1902 |
| Country | United States | United States |
| Employees | N/A | 35 |
| Industry | Biotechnology: Pharmaceutical Preparations | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.3M | 43.4M |
| IPO Year | 2010 | N/A |
| Metric | TLPH | MBBC |
|---|---|---|
| Price | $1.03 | $15.49 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 230.5K | 21.4K |
| Earning Date | 05-13-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,151,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $47.11 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.38 | $9.96 |
| 52 Week High | $1.57 | $15.75 |
| Indicator | TLPH | MBBC |
|---|---|---|
| Relative Strength Index (RSI) | 60.11 | 63.55 |
| Support Level | $1.01 | $12.90 |
| Resistance Level | $1.44 | $15.55 |
| Average True Range (ATR) | 0.08 | 0.79 |
| MACD | 0.02 | 0.10 |
| Stochastic Oscillator | 65.98 | 96.41 |
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
Marathon Bancorp Inc is a mid-tier holding company for Marathon Bank, a Wisconsin-chartered savings bank. The group operates as a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the group's revenue comes from interest income on loans and debt securities.